SARS-CoV-2 S1 D614G Mutant

Can't see this email? View it online

	Antibodies
	The latest antibodies news from News Medical

SARS-CoV-2 S1 D614G Mutant

Sino Biological has developed a recombinant S1 D614G and other mutations to help learning the biology of these variants, particularly in the context of vaccine and drug design.

Learn More

			B-Cell Protectors Whenever a germ gets into the human body, the immune system usually responds immediately to fight off the enemy attacker. One of our defense system's most important strategies involves B lymphocytes, also known as B cells, which produce antibodies that target and neutralize pathogens.

			Researchers identify antibody cocktail with potential to neutralize SARS-CoV-2 virus Researchers at the University of Maryland School of Medicine evaluated several human antibodies to determine the most potent combination to be mixed in a cocktail and used as a promising anti-viral therapy against the virus that causes COVID-19.

	CAR T Cell Therapy: Potential For Considerable Savings CAR T cell therapy is a new and, in some cases, highly effective form of immunotherapy to treat certain types of cancer of the blood and lymph system.

	Detecting antibodies in minutes using glowing proteins, thread and a smartphone camera To defend the body, the immune system makes proteins known as antibodies that latch onto the perceived threat, be it HIV, the new coronavirus or, as is the case in autoimmune disease, part of the body itself.

	Antibody and RNA testing can help track SARS-CoV-2 virus SARS-CoV-2 is usually tracked by two types of tests, reverse transcriptase PCR (rt-PCR) and antibody tests.

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions